This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Over the last three years, the FDA has approved six new drugs for hemophilia. An...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, open...
Pharma Marketing in 2025: A Conversation with Fierce Pharma
After failing to pass muster with England’s drug reimbursement watchdog earlier ...
Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the stea...
As U.S. President Donald Trump threatens a new round of tariffs as part of an on...
Four years into a Congressional probe of Big Pharma’s potential abuse of a 2017 ...
Kate Cronin, who took the marketing reins at Moderna in 2021 as it was skyrocket...
Ionis Pharmaceuticals and Arrowhead Pharmaceuticals have found a common cause am...
Novo Nordisk snagged an obesity asset from China's United Laboratories for up to...
The FDA has rejected Milestone Pharmaceuticals’ application for approval of Card...
As part of an ongoing expansion strategy around the globe, Chiesi announced this...
A former Pfizer-turned-GSK scientist reportedly told colleagues that Pfizer dela...
The FDA has approved Soleno Therapeutics' Vykat XR as the first treatment for in...
Merck & Co.’s subcutaneous formulation of Keytruda has matched up to the origina...
As part of an ongoing expansion strategy around the globe, Chiesi announced this...
Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. The ...
Japan faces a growing "Drug Loss" issue, but regulatory reforms and the J-ENTRY ...
As President Donald Trump renewed his threat of potential pharmaceutical tariffs...
As President Donald Trump renewed his threat of potential pharmaceutical tariffs...
Date: April 29-May 1, 2025 | San Diego, CA This invite-only summit, taking place...
Gilead’s HIV portfolio likely won’t feel too big of an impact from potential red...
In an untitled letter issued last Friday and made public this week, the FDA took...
In an untitled letter issued last Friday and made public this week, the FDA took...